• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Oct. 17

AUROBINDO Pharma Ltd is planning to sell one of its non-regulatory manufacturing facilities due to the shift in focus towards highly regulated markets.

The company informed the stock exchanges on Monday that it proposes to sell/dispose of unit-VII, situated at Jinnaram Mandal in Medak district of Andhra Pradesh.

According to the company, the net block value of this unit as on March 31, 2005 was 1.14 per cent of the total net block of its fixed assets.

The company is convening an extraordinary general meeting of shareholders through postal ballot to seek their consent for the proposed sale.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
KMML to raise capacity to 60,000 t by June

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line